PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System

by PanGenomic | Mar 30, 2023 | Business Update

Vancouver, British Columbia, Canada, March 30, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has signed a master services agreement with Hemex Health...

PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing

by PanGenomic | Mar 28, 2023 | Business Update

VANCOUVER, BC, March 28, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce the filing of its business acquisition report (the “BAR”) relating to its acquisition of...

Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System

by PanGenomic | Mar 22, 2023 | Business Update

VANCOUVER, BC, March 8, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its new Women’s DNA Report is now available and that it has expanded into new...

PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report

by PanGenomic | Mar 9, 2023 | Business Update

VANCOUVER, BC, March 8, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its new Women’s DNA Report is now available and that it has expanded into new...

PanGenomic Health Provides Corporate Update

by PanGenomic | Mar 2, 2023 | Business Update

VANCOUVER, BC, March 2, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. Acquisition of Mindleap Health Inc....